Document:

Employment Agreement

 Exhibit 10.8.c 
 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT 
 This SECOND AMENDMENT TO EMPLOYMENT
AGREEMENT (this “Second Amendment”) is entered into by and between Stereotaxis, Inc. (the “Company” or “Stereotaxis” or “we”) and Michael P. Kaminski ( “Employee”, “you” or
“your”), collectively referenced herein as “ the parties” or “we”. 
 WHEREAS, you and the Company have
previously entered into an At-Will Employment Agreement dated as of April 17, 2002, as amended by a First Amendment thereto on May 29, 2008 (as so amended, the “Employment Agreement”); 
 WHEREAS, you and the Company now desire to further amend the Employment Agreement (the
Employment Agreement, as amended by this Second Amendment, referenced herein as this “Agreement”) in light of the fact that you have agreed to accept the position of Chief Executive Officer (“CEO”) of Stereotaxis effective
on or about January 1st , 2009; and 
 NOW, THEREFORE, in consideration of your continued employment and the promises and mutual covenants set forth in the Employment Agreement, as well as the mutual covenants set forth herein, the parties agree as follows: 
 SECTION 1. Section 1 of the Employment Agreement is hereby deleted in its entirety and replaced with the following: 
 1.1 Position and Duties. Commencing on January 1, 2009 you shall hold the positions of President and Chief Executive Officer and shall
report to, and at all times be subject to the lawful direction of, the Board of Directors of the Company. Additionally, you shall serve as a member of the executive staff and lead the strategic decision-making of the Company from time to time. You
shall also serve as a member of the Board of Directors of the Company so long as you hold the positions of President and Chief Executive Officer, without additional compensation for such Board service. During the period of your employment by the
Company (the “Employment Period”), you shall devote your best efforts and full business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) to the business affairs of the
Company. You shall perform your duties and responsibilities to the best of your abilities in a diligent, trustworthy, businesslike and efficient manner. Nothing herein shall preclude you from pursuing your personal, financial and legal affairs, or,
subject to the prior written consent of the Board, (a) serving on any corporate or governmental board of directors (b) serving on the board of, or working for, any charitable, not-for-profit or community organization, or (c) pursuing
any other activity; provided that you shall not engage in any other business, profession, occupation or other activity, for compensation or otherwise, which would violate the provisions of this Agreement or would, in each case, and in the aggregate,
otherwise conflict or interfere with the performance of your duties and responsibilities hereunder, either directly or indirectly, without the prior written consent of the Board. 
  

 1 

 1.2 Base Salary. Commencing on January 1, 2009, the Company shall pay you as
compensation for services to be rendered hereunder a base salary in the amount of Four Hundred Thousand Dollars ($400,000.00) per year, payable in semi-monthly installments or otherwise in accordance with the Company’s normal payroll practices,
subject to increases, if any, as may be determined from time to time by the Company’s Board of Directors (or any duly authorized committee thereof, including without limitation the Compensation Committee) (the full board and any such committee
individually and collectively referred to herein as the “Board”), which periodic payments shall be subject to the usual and customary tax deductions, and any other deductions authorized by you as a participant, for example in certain of
our employee benefit plans. 
 1.3 Bonus Opportunity. You will be eligible to participate in a cash incentive bonus plan that
will provide for a “Target Bonus” of an amount equal to fifty percent (50%) of and maximum of one hundred per cent (100%) of your then-current base compensation, subject to achievement of Company objectives and performance goals
established for you by the Board, and subject to the Board’s determination whether and the extent to which such objectives and goals have been achieved and the amount of bonus payable as a result. 
 1.4 Equity Awards. 
 (a) You will receive One
Hundred Twenty-Five Thousand (125,000) Stock Appreciation Rights (“SARs”) upon the execution and delivery of this Second Amendment and effective upon and conditioned on the final approval of the Board or the Compensation Committee
thereof, which shall be undertaken at its first scheduled meeting following said execution and delivery. 
 (b) Thereafter, subject to the approval of the
Board, you will be eligible to receive additional equity grants in 2009. 
 1.5. Termination. 
 a) Termination by Company With Cause. Your employment hereunder is at will, and may be may be terminated at any time by Company with or without “Cause”.
For purposes of this Agreement, “Cause” shall mean: (i) embezzlement, theft or other intentional misappropriation of any property of Company, (ii) any willful act involving moral turpitude which brings disrepute or disparagement
to the Company or substantially impairs its good will and reputation, or results in a conviction for or plea of guilty to a felony involving moral turpitude, fraud or misrepresentation, (iii) material neglect of your duties as CEO pursuant to
this Agreement, (iv) material breach of your fiduciary obligations to Company, or (v) any chemical dependence which materially affects the performance of your duties and responsibilities to Company; provided that in the case of the
misconduct set forth in clauses (iii), (iv) and (v) above, you will be given written notice setting forth in reasonable detail the purported acts which constitute Cause, and you will be given the opportunity within thirty (30) days to
appear before the Board with counsel to respond to any such allegations. 
 b) Termination Without Cause. If your employment is terminated by the
Company without Cause, i) you shall receive salary continuance equal to your then current monthly base salary for the twenty-four (24) month period next following your without-Cause termination; however, if you are reemployed by the Company or
find comparable employment during that twenty–four month period next following your without-Cause termination, such salary continuation payments will be 

  

 2 

 
offset by the amount of any salary from your new employer ( or us) commencing upon such new employment; and ii) in addition to the payments set forth in
(i) above, the number of stock options, stock appreciation rights or other equity awards subject to vesting that would have vested over the 12 month period following the date of your without-Cause termination shall be automatically fully vested
as of the date of the termination; and iii) you will thereafter have an exercise period of one (1) year next following your termination date, each option being exercisable by five (5) business days prior written notice of exercise to the
Company. 
 c) Change of Control. If, in the event of a Change of Control of the Company under which the Company is not the surviving entity you are
not offered a comparable position and salary in the surviving entity after the Change of Control, you shall receive salary continuance equal to your then current monthly base salary for the twenty-four (24) month period next following your
without-Cause termination or the said Change of Control, subject to your compliance with any post-termination restrictions and covenants herein, and provided that, as a condition precedent to your receipt of the salary continuance payments, you
shall execute a release which releases the Company and its representatives from any and all claims that you may have against us. However, if you are reemployed by the Company or find comparable employment during that twenty–four month period
next following your without-Cause termination, such salary continuation payments will be offset by the amount of any salary from your new employer (or us) commencing upon such new employment. A Change of Control, for purposes of this Second
Amendment, is (i) an event whereby any natural person, corporation, general partnership, limited partnership, joint venture, proprietorship or other business organization (each, a “Person”), including such Person’s affiliates, or
“group” (as such term is defined under Section 13(d) of the Securities Exchange Act of 1934, as amended) acquires beneficial ownership of capital stock of Stereotaxis entitling the holder(s) thereof to more than fifty percent
(50%) of the voting power of the then outstanding capital stock of Stereotaxis with respect to the election of directors of Stereotaxis, or (ii) a sale or transfer of all or substantially all of the assets of Stereotaxis to any Person.

 d) Pro rata Payment of Bonus. In the event of termination under b) or c) above in a year in which you have served as CEO and President for no less
than six months, you will be entitled to receive a bonus from any bonus plan in which you were a participant as a member of management, which shall be paid on the same basis and at the same level as the other management employees who remain employed
by the Company, pro rated on the basis of the number of days in the year that you worked prior to your termination. 
 e) Medical and Dental Insurance
Continuation. In the event of termination under b) or c) above you shall be entitled to participate in the Company’s then-prevailing medical and dental plans upon the same contribution terms as those provided to or for the benefit of the
Company’s employees from time to time during the 24-month period following your Separation Date, after which time such benefits will cease. This obligation will cease sooner than twenty-four months following your date of termination, if and at
such time as you assume a full-time position with any other employer. Your participation in all other Company provided benefit plans and programs shall cease as of your termination date. 
 f) Release of Claims. The salary continuation payments and other post-termination compensation benefits are conditioned on and subject to your compliance with all post-termination restrictions and covenants and
provided that, as a condition precedent to your receipt of the salary continuance payments you shall execute a release which releases the Company and its 

  

 3 

 
representatives from any and all claims that you may have against us. You are not entitled to salary continuation if your termination is voluntary or for
cause. 
 SECTION 2. The Confidentiality and NonCompete Agreement previously entered into by the Parties in connection with the
Employment Agreement (Exhibit A thereto) is hereby deleted in its entirety and replaced with the following: 
 2.1 Confidential Information,
Non-Competition, and Non-Disparagement. 
 a) Definitions. For purposes of this Agreement: 
 (i) “Business” shall mean and include the development, manufacture and sale of equipment, software, devices, and methods in the field of
remote, computer-controlled or computer-aided navigation and delivery of interventional disposable devices, for endovascular applications (including electrophysiology and interventional cardiology), and within the peripheral vasculature in
cardiology applications, with or without the use of magnetic devices or systems, and related interventional workstations and networks, used in or with interventional medical procedures, and related areas of research and business development being
currently implemented by the Company, all as presented from time to time to the Stereotaxis Board of Directors. 
 (ii) “Related
Parties” shall mean and include (a) any and all of our customers served by the Company or any of our personnel or distributors or agents or at any time during the final two years of your employment with us, (b) material investors
whom you contacted or met or corresponded with concerning an investment in or loan to the Company during your final two years of employment with us, (c) companies or entities or their representatives with respect to which you prepared and
submitted materials to the Board of Directors for the purpose of pursuing a collaboration or alliance and associated Confidential Information at any time during your final two years of employment with us, (d) prospective new customers,
investors or collaborators which become affiliated with us during the term of this Agreement. 
 (iii) “Restricted Period”
shall mean the period of your employment with us plus two (2) years immediately following the date of your termination for any reason. 
 (iv) “Territory” shall mean the geographic regions for which you have executive, managerial, supervisory, sales, marketing and/or other responsibilities at any time during your employment with us, which you acknowledge is
worldwide. 
 b) Confidentiality. 
 (i) You agree to keep secret and confidential, and not to use or disclose to any third parties, including but not limited to Related Parties, except as required for the performance of your responsibilities on behalf of the Company any
confidential or proprietary information, including but not limited to intellectual property, systems, programs, analyses, and/or other information of Company acquired during the course or as a result of your employment with Company (collectively,
“Confidential Information”). Excluded from the scope and definition of Confidential Information is information made generally available to the public in any manner other than a breach of this Paragraph (b) by you, and information
required to be disclosed by you 

  

 4 

 
pursuant to process of law. In that regard and in recognition that due to the nature and duration of your employment by the Company the use and disclosure of
Confidential Information would inevitably result from your involvement with or engagement by the Company’s competitors or Related Parties in connection with Business as defined herein, you agree that the covenants relating to non-competition in
Paragraph (c) hereinbelow are appropriate and fair and necessary to the protection of Confidential Information hereunder. 
 (ii) All
notes, records, correspondence, data, hardware, software, documents or the like obtained by or provided to Company regarding the Business, or otherwise made, produced, or compiled during the course or as a result of your employment with Company
which contain Confidential Information, regardless of the type of medium that such is preserved in, are the sole and exclusive property of Company, and shall be surrendered to Company upon your termination for any reason. 
 (iii) Based on the information available to you in your current position, you covenant that you have not disclosed, and will not disclose any
information, whether confidential, proprietary, or otherwise, which you are not legally free to disclose. You agree to adhere to these commitments now and in the future and further, you agree that during the Restricted Period, Company may contact
you and request your cooperation and consultation in securing data or information about which you may have particular knowledge, and you agree to fully and confidentially cooperate in any such consultations. 
 c) Non-Competition; Restrictive Covenants. 
 (i) You hereby acknowledge and agree that (a) the Company competes globally for and has relationships with customers, collaborators, employees, distributors, agents, and investors throughout the world; and has spent substantial time,
money and effort over the years in developing and solidifying its relationships with Related Parties and protecting its Confidential Information and goodwill, (b) long-term customer and investor relationships and collaborations with other
companies can be difficult to develop and require a significant investment of time, effort and expense, (c) we compensate our employees to, among other things, develop and preserve goodwill, loyalty and contacts among Related Parties, as well
as Confidential Information, for and on behalf of us, (d) the Company, in all fairness, needs certain protection in order to ensure that there is no disclosure, misappropriation or misuse of any Confidential Information, which would cause
injury or disruption to or interference with the operation of the Company Business, (e) the Company is hereby agreeing to pay you based upon your assurances and promises contained herein not to misuse or divert the Company’s Confidential
Information, and (f) because of your role in the Company, any interactions concerning the Business that you have with competitors or Related Parties after termination of your employment may result in the disclosure of Confidential Information
or may affect the Company’s relationships with competitors or Related Parties. 
 (ii) In consideration of the foregoing, as well as the
Company’s entering into this Agreement and making the payments and granting the other benefits herein, except as required for the performance of your responsibilities on behalf of the Company you shall not during the Restricted Period, directly
or indirectly, on your behalf or for or on behalf of any other person, firm, corporation or entity. 
  

 5 

 (A) provide consultative services with or without pay, own, manage, operate, join,
control, participate in, or be connected as a stockholder, general partner, officer, director, agent, consultant, independent contractor, or otherwise with, any business, individual, partner, firm, corporation, or other entity which is then in
competition with the Company or engaged in Business, including without limitation to the generality of the foregoing, those firms listed on Attachment A or the divisions, departments, or affiliates engaged in the Business within those
firms listed on Attachment B, 
 (B) provide any executive, managerial, supervisory, sales, marketing, research,
or customer-related services to assist any competitor in competing, directly or indirectly, against us with respect to Business, in the Territory; 
 (C) obtain or use our Confidential Information and/or to divert goodwill generated and/or developed for or on behalf of us; 
 (D) solicit, divert, or take away, or attempt to solicit, divert or take away, from us the business of any customers for the purpose of selling or providing to or servicing for any such customer any product or service
which is part of the Business; 
 (E) knowingly to cause or attempt to cause any customer of Company to terminate or reduce
their existing relationships with us; or 
 (F) knowingly to solicit, induce, or hire, or attempt to solicit, induce, or hire,
any employee, consultant, or distributor of the Company to leave the employ of us and/or to work for any competitor of the Company. 
 d)
Nondisparagement. You and we agree that neither party will in any way disparage the other party including current or former officers, directors and employees of the Company, and neither party will, at any time, make or solicit any
comments, statements or the like to the media or to others, including their agents or representatives, that may be considered to be derogatory or detrimental to the good name or business reputation of either party. 
 e) Acknowledgements Regarding Restrictions. 
 (i) We agree the restrictions herein shall apply only to prevent you from making contacts and providing services relating to the Business, and/or regarding which you have Confidential Information at any time, except as required for the
performance of your responsibilities on behalf of the Company. You agree that the restrictions herein, both separately and in total, are reasonable and enforceable in view of, among other things, (A) our legitimate interests in protecting
Confidential Information, goodwill and relationships with Related Parties, (B) the narrow range of the activities prohibited, (C) the Confidential Information to which you have had and will have access, which you agree has a useful
competitive life of more than two years, and (D) your background, which is such that the restrictions should not impose any undue hardship on you. 
 (ii) None of these restrictions is intended to prevent you from owning up to one percent (1%) of the publicly traded stock of any company, or after termination of your employment with the Company, providing
services to or being employed by firms such as those listed on 

  

 6 

 
Attachment B in divisions, departments, or affiliates within those firms not engaged in Business, so long as the restrictions in Sections 2.1(b) or
(c), or any of your duties or obligations under the Confidentiality or Non-Competition provisions of this Agreement are not violated thereby. 
 (iii) In the event of a breach or threatened breach of any of your duties or obligations under the Confidentiality or Non-Competition provisions hereof, the Company shall be entitled, in addition to any other legal or equitable remedies it
may have in connection therewith (including any right to damages that it may suffer), to temporary, preliminary and permanent injunctive relief restraining such breach or threatened breach. You hereby expressly acknowledge that the harm which
might result to the Company as a result of any noncompliance by you with any of these provisions would be largely irreparable. You specifically agree that if there is a question as to the enforceability of any of the restrictions in 2.1(c)(ii)p
you will not engage in any conduct inconsistent with or contrary to such provision during the Restricted Period unless and until the question has been resolved by a court of competent jurisdiction in a manner that would permit such conduct.

 (iv) Company’s failure to enforce at any time any of the provisions of this Agreement or to require at any time your performance of
any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect either the validity of this Agreement, or any part hereof, or the right of Company thereafter to enforce each and every provision in accordance
with the terms of this Agreement. 
 (v) If any provision of this Agreement is adjudicated to be invalid or unenforceable under applicable
law in any jurisdiction, the validity or enforceability of the remaining provisions thereof shall be unaffected as to such jurisdiction and such adjudication shall not affect the validity or enforceability of such provisions in any other
jurisdiction. To the extent that any provision of this Agreement is adjudicated to be invalid or unenforceable because it is overbroad, that provision shall not be void, but rather shall be limited only to the extent required by applicable law and
enforced as to limited. The parties expressly acknowledge and agree that this Section is reasonable in view of the parties’ respective interests. 
 2.2 Conflict of Interest You shall take no action or obtain any direct or indirect interests in or relationships with any organization that might affect the objectivity and independence of your judgment or conduct in carrying
out duties and responsibilities to Company under this Agreement. Any such actions or interests which may even create the appearance of a conflict of interest shall be promptly brought to the attention of Company. 
 2.3 Notification of Prospective or Subsequent Employers. You agree to notify any prospective employer of the existence and terms of this Agreement, prior
to acceptance of employment outside of the Company. Company may inform any person or entity subsequently employing You, or evidencing an intention to employ you, of the nature of the information Company asserts to be Confidential Information, and
may inform that person or entity of the existence of this Agreement, the terms hereof, and provide to that person or entity a copy of this Agreement. 
 2.4 Inventions and Patents. You agree that you will promptly, from time to time, fully inform and disclose to Company all inventions, designs, improvements, and discoveries which you now 

  

 7 

 
have or may discover during the term of this Agreement which pertain or relate to the Business of Company or to any experimental work carried on by Company,
whether conceived by you alone or with others and whether or not conceived during regular working hours. All such inventions, designs, improvements, and discoveries shall be the exclusive property of Company. You shall assist Company at
Company’s sole expense, to obtain patents on all such inventions, designs, improvements, and discoveries deemed patentable by Company, and shall execute all documents and do all things necessary to obtain patents, vest Company with full and
exclusive title thereto, and protect the same against infringement by others. You shall be entitled to no additional compensation for any and all inventions or designs made during the course of this Agreement. 
 SECTION 3. All other provisions of the Employment Agreement not hereby amended shall remain in full force and effect. 
 SECTION 4. This Second Amendment and the Employment Agreement shall be read and construed together as a single instrument. 
 SECTION 5. This Second Amendment and the rest of this Agreement shall be interpreted in accordance with and governed by the laws of the
State of Missouri. 
 IN WITNESS WHEREOF, the parties have executed this Second Amendment on the date first written above. 
  

					
		 	STEREOTAXIS, INC.
			
	Date: December 10, 2008	 	By:	 	 /s/ Fred A. Middleton

		 	Name:	 	Fred A. Middleton
		 	Title:	 	Chairman of the Board of Directors
		
	Date: December 10, 2008	 	EMPLOYEE:
		
		 	 /s/ Michael P. Kaminski

		 	Michael P. Kaminski

  

 8 

 Attachment A 
  

	 	1.	Catheter Robotics 

	 	2.	Corindus 

	 	3.	Hansen 

	 	4.	Magnetecs 

	 	5.	SmithCurl/Curlview 

	 	6.	Systems One 

  

 9 

 Attachment B 
  

	 	1.	Atricure 

	 	2.	Boston Scientific 

	 	3.	Biosense Webster 

	 	4.	Biotronik 

	 	5.	GE Medical 

	 	6.	Intuitive Surgical 

	 	7.	Medtronics 

	 	8.	Philips 

	 	9.	Pulse Technologies 

	 	10.	Siemens 

	 	11.	St. Jude 

	 	12.	Swiss Medical 

  

 10Severence Agreement

 Exhibit 10.11.b 
 SEVERANCE AGREEMENT AND RELEASE 
 This Severance Agreement and Release (“Agreement”)
is made between Stereotaxis, Inc. (“Stereotaxis”), including its divisions, subsidiaries, parent and affiliated corporations, their successors and assigns (individually and collectively “Stereotaxis”) and Kevin Shifrin
(“Employee”). 
 WHEREAS, Stereotaxis and Employee desire to terminate their employment relationship and settle all legal rights
and obligations resulting from Employee’s employment with Stereotaxis. 
 NOW, THEREFORE, in consideration of the foregoing and the
mutual promises, representations and undertakings of the parties set forth herein, the adequacy and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	Separation Date. Employee’s employment with Stereotaxis will terminate effective December 31, 2008. 

  

	2.	In consideration for Employee’s execution of this Severance Agreement and Release, Stereotaxis agrees as follows: 

  

	 	(a)	Severance. Employee will receive 26 weeks of base pay in the amount of $5,192.31 per week as severance, for a total payment of $135,000, less deductions required by
law. Employee’s severance will payable in accordance with Stereotaxis’ normal payroll dates and will commence once the revocation period set forth in paragraph 6(e) has elapsed without Employee revoking this Release.

  

	 	(b)	Additional Payment. Employee will receive an additional lump sum payment in the amount of $100,000 to be paid on first the regularly scheduled payroll date after this
agreement has been executed and the revocation period has passed. 

  

	 	(c)	Vacation. Employee will be paid $4,475.77, less deductions required by law, as full and complete payment of all remaining vacation hours and personal time earned but
not used by Employee’s Separation Date. 

  

	 	(d)	Insurance. Stereotaxis will permit Employee to exercise Employee’s COBRA conversion privileges as provided by law, effective January 1, 2009. Stereotaxis
will pay the cost under COBRA for continuing Employee’s group medical and dental insurance from January 1, 2009 through July 2, 2009, provided Employee’s regular monthly contribution is made by deduction from the severance
payment. Thereafter, Employee shall be responsible to pay the cost to continue Employee’s group medical insurance under COBRA. 

  

	3.	 The parties agree that the compensation and benefits described above provided Employee by Stereotaxis represents additional compensation and benefits to which
Employee would 

	 	 
not be entitled absent this Agreement. The parties further agree that the compensation and benefits described above constitute the total understanding of all
compensation and benefits payable by Stereotaxis to Employee with regard to Employee’s employment by Stereotaxis and the termination thereof, and that no other compensation, commissions, bonuses, benefits or payments of any kind will be paid
other than the amounts set forth above. 

  

	4.	Employee hereby waives and releases Stereotaxis, its subsidiaries, related, parent and affiliated corporations and business entities, their successors and assigns, and their past
and present officers, directors, shareholders, employees and agents (“the Released Parties”) from any and all claims made, to be made, or which might have been made of whatever nature, whether known or unknown, since the beginning of time
through the date of this Agreement, including, but not limited to, any claim Employee may have under any agreements which Employee may have with any of the Released Parties, any claims that arose as a consequence of Employee’s employment by
Stereotaxis, or arising out of the termination of the employment relationship, or arising out of any acts committed or omitted during or after the existence of the employment relationship through the date of this Agreement. Such release and waiver
of claims will include, but shall not be limited to, those claims which were, could have been, or could be the subject of an internal grievance or appeal procedure or an administrative or judicial proceeding filed either by Employee or on
Employee’s behalf under any federal, state or local law or regulation, any claim of discrimination under any state or federal statute, regulation or ordinance including, but not limited to Titles 29 and 42 of the United States Code, Title VII
of the Civil Rights Act of 1964, as amended, the Employee Retirement Income Security Act of 1974, as amended, the Civil Rights Act of 1991, the Americans with Disabilities Act of 1990, the Civil Rights Act of 1866, the Rehabilitation Act of 1973, as
amended, the Family and Medical Leave Act, the Older Worker Benefit Protection Act, the Missouri Human Rights Act, City of St. Louis Ordinance 62710, any other federal, state or local law, ordinance or regulation regarding employment, discrimination
in employment or termination of employment, any claims for breach of contract, wrongful termination, promissory estoppel, detrimental reliance, negligent or intentional infliction of emotional distress, or any other actions at common law, in
contract or tort, all claims for lost wages, bonuses, commissions, benefits, expenses, severance, service letter, re-employment, compensatory or punitive damages, attorney’s fees, and all claims for any other type of legal or equitable relief.
Employee further waives all rights to future employment with Stereotaxis and agrees not to apply for employment with Stereotaxis. 

 This Release does not affect any vested rights Employee may have under any retirement plan of Stereotaxis. 
  

	5.	Employee covenants not to sue Stereotaxis or any other party released herein with respect to any claim released pursuant to this Agreement. 

  

	6.	By execution of this document, Employee expressly waives any and all rights to claims under the Age Discrimination in Employment Act of 1967, 29 U.S.C. § 621, et seq.:

  

 2 

	 	(a)	Employee acknowledges that Employee’s waiver of rights or claims refers to rights or claims arising under the Age Discrimination in Employment Act of 1967, is in writing and is
understood by Employee; 

  

	 	(b)	Employee expressly understands that by execution of this document, Employee does not waive any rights or claims that may arise after the date the waiver is executed;

  

	 	(c)	Employee acknowledges that the waiver of Employee’s rights or claims arising under the Age Discrimination in Employment Act is in exchange for the consideration outlined in
this Agreement which is above and beyond that to which Employee is entitled; 

  

	 	(d)	Employee acknowledges that Stereotaxis expressly advised Employee to consult an attorney of Employee’s choosing prior to executing this document and that Employee has been
given a period of not less than forty-five (45) days within which to consider this Agreement; 

  

	 	(e)	Employee acknowledges that Employee has been advised by Stereotaxis that Employee is entitled to revoke (in the event Employee executes this document) Employee’s waiver of
rights or claims arising under the Age Discrimination in Employment Act within seven (7) days after executing this document by notifying Stereotaxis in writing at: Stereotaxis, 4320 Forest Park Avenue, Suite 100, St. Louis, Missouri 63108,
Attn: Dave Giffin that Employee intends to revoke this waiver and that said waiver will not and does not become effective or enforceable until the seven (7) day period has expired. Employee agrees that payment of monies due under this executed
and unrevoked waiver shall not be payable until the seven (7) day revocation period has expired and Employee has not revoked this waiver; 

  

	 	(f)	Employee further understands that this Agreement is requested in connection with an exit incentive or other employment termination program and acknowledges receipt of a written
description of the class, unit, or group of employees covered by such program, as well as the job titles and ages of all employees eligible or selected for the program and the ages of all employees in the same job titles not eligible or selected for
the program. 

  

	7.	Employee agrees that the terms and provisions of this Agreement and the fact and amount of consideration paid pursuant to this Agreement, shall at all times remain confidential and
not be disclosed to anyone not a party to this Agreement, other than (1) to the extent disclosure is required by law, or (2) to Employee’s spouse, or (3) to Employee’s attorneys, accountant and tax advisors who have a need
to know in order to render Employee professional advice or service. Employee agrees to ensure said individuals maintain such confidentiality. 

  

	8.	 Employee agrees not to in any way disparage Employer nor make or solicit any comments, statements, or the like to the media or to any third party that may
be 

  

 3 

	 	 
considered to be derogatory or detrimental to the good name and/or business reputation of Employer, including its directors, officers, employees,
agents, representatives and customers. 

  

	9.	Employee agrees to promptly return to Stereotaxis any and all electronic media files, company keys, company vehicles, credit cards, equipment, documents, papers, records, notes,
memoranda, plans, files, and other records containing information concerning Stereotaxis or its employees, customers, or operations. 

  

	10.	Nothing contained in this Agreement shall be construed to require the commission of any act contrary to law or to be contrary to law, and whenever there is any conflict between any
provision of this Agreement and any present or future statute, law, government regulation or ordinance contrary to which the parties have no legal right to contract, the latter shall prevail, but in such event the provisions of this Agreement
affected shall be curtailed and restricted only to the extent necessary to bring them within legal requirements. 

  

	11.	The existence and execution of this Agreement shall not be considered, and shall not be admissible in any proceeding, as an admission by Stereotaxis or anyone released hereby, of
any liability, error, violation or omission. 

  

	12.	This Agreement shall be governed by, and construed and interpreted according to, the laws of the State of Missouri and whenever possible, each provision herein shall be interpreted
in such manner as to be effective or valid under applicable law. 

  

	13.	The parties acknowledge this Agreement constitutes the entire agreement between them superceding all prior written and oral agreements or understandings between the parties, with
the exception that Employee shall continue to be bound by any confidentiality and/or non-competition agreement executed by Employee with Stereotaxis. 

  

	14.	The parties hereto agree that this Agreement may not be modified, altered or changed except by written agreement signed by the parties hereto. 

  

	15.	Employee acknowledges Employee has read this Agreement, that Employee has had a reasonable amount of time to consider its terms, that the only consideration for Employee signing
this Agreement are the terms stated above, that no other promise, agreement, statement or representation of any kind has been made to Employee by any person or entity to cause Employee to sign this Agreement, that Employee is competent to execute
this Agreement, that Employee has had an adequate opportunity to discuss this Agreement with an attorney and Employee has done so or has voluntarily elected not to do so, that Employee fully understands the meaning and intent of this Agreement and
that Employee is voluntarily executing it of Employee’s own free will. 

  

 4 

	
	AGREED TO AND ACCEPTED:
	
	 /s/ Kevin Shifrin

	Kevin Shifrin

 STATE OF ARIZONA 
 COUNTY OF MARICOPA 
 COMES NOW Kevin Shifrin, who states to me that he/she has read and understands the foregoing Agreement and
agrees to and accepts its terns and conditions as a free act of his/her own volition. 
 Subscribed and sworn to before me this 9 day of
January, 2009. 
  

	
	 /s/ Steven J. Moog

	Notary Public

 My Commission Expires: 
  

			
	STEREOTAXIS:
		
	By:	 	 /s/ David Giffin

		
	Date:	 	 1/14/09

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]